PMA device
OPTIMIZER Smart, OPTIMIZER Smart Mini
Impulse Dynamics (Usa), Inc. · Implantable Pulse Generator (QFV, Class III) · First FDA decision Aug 18, 2022, newest Aug 18, 2022Heart failure
Last checked: Nov 20, 2026Source: FDA, CMS, ClinicalTrials.gov, PubMed
FDA decisions
1
PMA pathway
Device trials
8
Naming "OPTIMIZER Smart OPTIMIZER"
MAUDE reports
0
Brand "OPTIMIZER Smart OPTIMIZER", since 2015
PubMed studies
0
Mentioning "OPTIMIZER Smart OPTIMIZER"
AI summary across all sources
Written by AI from the FDA, CMS, ClinicalTrials.gov, MAUDE and PubMed data on this page, plus web searches for payment facts.
Product review deck
A slide deck reviewing OPTIMIZER Smart, OPTIMIZER Smart Mini
About ten slides on the technology, clinical evidence, regulatory history and commercialization, built with AI from the data on this page and web research, with sources. Download it as PowerPoint to edit or as PDF to share.
- Executive summary and key facts
- Technology, with pictures of the device
- Clinical evidence and trials
- Regulatory history and safety
- Reimbursement, market and competition
- Risks, outlook and sources
AI-written from public data and may contain mistakes. Check each fact against its source before relying on it. Not investment, legal, reimbursement or medical advice.
FDA decisions
The newest 1 of 1 decisions filed under this name.
- OPTIMIZER Smart, OPTIMIZER Smart MiniPMA supplement
P180036-S015 · Decided Aug 18, 2022 · 27 days after receipt · Normal 180 Day Track No User Fee
Device type: Implantable pulse generator (QFV) · Cardiology
Medicare coverage
National and local coverage documents whose titles match this device or its device type. Payment add-ons (NTAP, pass-through, TCET) and likely codes are covered in the summary above.
No Medicare coverage document has a title matching this device or device type. Many devices are paid under existing codes without one.
Clinical trials
Device studies on ClinicalTrials.gov that name "OPTIMIZER Smart OPTIMIZER", any status and sponsor, newest update first.
- Assessment of CCM in HF With Higher Ejection FractionPivotal-lookingRecruiting
Impulse DynamicsNot on our public-company list
NCT05064709 · 1,500 participants (planned) · Start Feb 3, 2022 · Primary completion Feb 1, 2029
Device: Cardiac Contractility Modulation Therapy via OPTIMIZER™ Smart Mini System; OPTIMIZER™ Smart Mini System · For: Heart Failure; Heart Failure With Preserved Ejection Fraction; Heart Failure With Mid Range Ejection Fraction and 2 more
Sites: Birmingham, Alabama; Mesa, Arizona; Scottsdale, Arizona · 67 sites in all
7 more trials with a free account
Adverse event reports (MAUDE)
Reports received since 2015 naming the brand "OPTIMIZER Smart OPTIMIZER", and for the whole product code for context.
This brand
0 reports: 0 malfunction, 0 injury, 0 death
Whole product code QFV
183 reports: 61 malfunction, 119 injury, 3 death
Newest reports for this brand
No MAUDE reports name this brand.
Recalls
From FDA's recall database. FDA lists each recalled product separately, so one recall can appear several times. A recall is often a correction or a labeling change, not a removal from the market.
No recall in FDA's data is linked to these FDA numbers.
Published research
The most relevant PubMed records for "OPTIMIZER Smart OPTIMIZER"[tiab]. The summary above synthesizes these.
No PubMed record mentions this device by name.
Other devices of this type
Also filed under product code QFV.
- OPTIMIZER Smart SystemImpulse Dynamics (Usa), Inc. · PMA 2025
- OPTIMIZER Smart Mini Implantable Pulse Generation (IPG)Impulse Dynamics (Usa), Inc. · PMA 2023
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.